The efficacy and safety of evinacumab, a fully human monoclonal antibody against ANGPTL3, was investigated in the Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia trial (70). The gene discussed is ANGPTL3; the disease is homozygous familial hypercholesterolemia.